Login to Your Account

Rare disease firm Aldexa Therapeutics files for $20M IPO

By Peter Winter
BioWorld Insight Editor

Tuesday, January 7, 2014
Burlington, Mass.-based Aldexa Therapeutics Inc. added itself to the crowded initial public offering (IPO) “runway,” filing its S-1 with the SEC to generate up to $20 million in an IPO.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription